Hospira patent expiration

1. Daptomycin patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10357535 HOSPIRA Daptomycin formulations and uses thereof
Sep, 2033

(9 years from now)

US9655946 HOSPIRA Daptomycin formulations and uses thereof
Sep, 2033

(9 years from now)




Drugs and Companies using DAPTOMYCIN ingredient

Market Authorisation Date: 21 June, 2021

Treatment: Treatment of complicated skin and skin structure infections and s. aureus bloodstream infections (bacteremia) including those with right-sided infective endocarditis by reconstituting and administerin...

Dosage: POWDER

More Information on Dosage

DAPTOMYCIN family patents

Family Patents

2. Liposyn Iii 30% patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9717852 HOSPIRA Cartridge holder and pen-type injector
Apr, 2033

(8 years from now)




Drugs and Companies using SOYBEAN OIL ingredient

Market Authorisation Date: 13 January, 1998

Treatment: NA

Dosage: INJECTABLE

More Information on Dosage

LIPOSYN III 30% family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Precedex patent expiration

PRECEDEX's oppositions filed in EPO
PRECEDEX IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US4910214 HOSPIRA Optical isomer of an imidazole derivative medetomidine as an alpha-2-receptor agonist
Jul, 2013

(11 years ago)

US4910214

(Pediatric)

HOSPIRA Optical isomer of an imidazole derivative medetomidine as an alpha-2-receptor agonist
Jan, 2014

(10 years ago)

US6716867 HOSPIRA Use of dexmedetomidine for ICU sedation
Mar, 2019

(5 years ago)

US6716867

(Pediatric)

HOSPIRA Use of dexmedetomidine for ICU sedation
Oct, 2019

(4 years ago)

US8338470 HOSPIRA Dexmedetomidine premix formulation
Jan, 2032

(7 years from now)

US8455527 HOSPIRA Methods of treatment using a dexmedetomidine premix formulation
Jan, 2032

(7 years from now)

US9616049 HOSPIRA Dexmedetomidine premix formulation
Jan, 2032

(7 years from now)

US8242158 HOSPIRA Dexmedetomidine premix formulation
Jan, 2032

(7 years from now)

US10016396 HOSPIRA Dexmedetomidine premix formulation
Jan, 2032

(7 years from now)

US8648106 HOSPIRA Dexmedetomidine premix formulation
Jan, 2032

(7 years from now)

US9320712 HOSPIRA Dexmedetomidine premix formulation
Jan, 2032

(7 years from now)

US9616049

(Pediatric)

HOSPIRA Dexmedetomidine premix formulation
Jul, 2032

(7 years from now)

US8455527

(Pediatric)

HOSPIRA Methods of treatment using a dexmedetomidine premix formulation
Jul, 2032

(7 years from now)

US8242158

(Pediatric)

HOSPIRA Dexmedetomidine premix formulation
Jul, 2032

(7 years from now)

US8338470

(Pediatric)

HOSPIRA Dexmedetomidine premix formulation
Jul, 2032

(7 years from now)

US8648106

(Pediatric)

HOSPIRA Dexmedetomidine premix formulation
Jul, 2032

(7 years from now)

US9320712

(Pediatric)

HOSPIRA Dexmedetomidine premix formulation
Jul, 2032

(7 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Indication(I-577) Oct 17, 2011
M(M-61) Jun 17, 2016
Pediatric Exclusivity(PED) Dec 17, 2016
New Patient Population(NPP) Dec 16, 2025

Drugs and Companies using DEXMEDETOMIDINE HYDROCHLORIDE ingredient

Market Authorisation Date: 31 January, 2020

Treatment: Use for sedation; Intensive care unit sedation

Dosage: INJECTABLE

How can I launch a generic of PRECEDEX before it's drug patent expiration?
More Information on Dosage

PRECEDEX family patents

Family Patents